Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05245500
Title Phase 1/2 Study of MRTX1719 in Solid Tumors With MTAP Deletion
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Mirati Therapeutics Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Mayo Clinic RECRUITING Phoenix Arizona 85054 United States Details
Sarah Cannon Research Institute at HealthONE RECRUITING Denver Colorado 80218 United States Details
Mayo Clinic RECRUITING Jacksonville Florida 32224 United States Details
Sarah Cannon Research Institute at Florida Cancer Specialists RECRUITING Orlando Florida 32827 United States Details
Dana Farber Cancer Institute RECRUITING Boston Massachusetts 02215 United States Details
Mayo Clinic RECRUITING Rochester Minnesota 55905 United States Details
Memorial Sloan Kettering Cancer Center RECRUITING New York New York 10065 United States Details
NorthShore Hematology Oncology Associates P.C New York Cancer and Blood Specialists RECRUITING Port Jefferson Station New York 11776 United States Details
Sarah Cannon Research Institute RECRUITING Nashville Tennessee 37203 United States Details
MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
Oncology Consultants, P.A. RECRUITING Houston Texas 77030 United States Details
START Center for Cancer Care RECRUITING San Antonio Texas 78229 United States Details
NEXT Virginia RECRUITING Fairfax Virginia 22031 United States Details
Froedtert Hospital & the Medical College of Wisconsin RECRUITING Milwaukee Wisconsin 53226 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field